secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001493152-24-004161
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow expands board to six members, appoints Dr. Adrienne Graves and Lauren Silvernail
--------------------------------------------------------------------------------

- Board size increased from 4 to 6 members effective January 26, 2024.
- Dr. Adrienne Graves brings ophthalmology expertise as former CEO of Santen Inc. and board member at multiple eye-care firms.
- Lauren Silvernail brings financial and strategic expertise as former CFO of Evolus, Revance, and ISTA Pharmaceuticals.
- Appointments are effective immediately; press release issued January 29, 2024.
- Neither new director has been assigned to a board committee at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/0001493152-24-004161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer